First US Adult ADHD Guidelines Finally on the Way? First US Adult ADHD Guidelines Finally on the Way?
The first US clinical guidelines for adult ADHD are expected to be released this fall, providing a long-overdue, much-needed, standardized framework.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 11, 2024 Category: Neurology Tags: Psychiatry News Source Type: news
Fresh Tri CEO, Dr. Kyra Bobinet, Illuminates the Path to Overcoming "Failure Disease" in Her New Book, Unstoppable Brain
Physician turned behavior change expert, author, and entrepreneur is healing individuals from "Failure Disease" with groundbreaking neuroscience SILICON VALLEY, Calif., April 11, 2024 /PRNewswire-PRWeb/ -- Fresh Tri, Inc., a pioneering neuroscience-based health and wellness technology... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 11, 2024 Category: Pharmaceuticals Tags: PDT Source Type: news
Gene Discovery May Lead to Better Alzheimer's Treatments
THURSDAY, April 11, 2024 -- The discovery of a gene variant that rids the brain of toxic plaques linked to Alzheimer ' s might lead to new treatments for the disease, researchers report.
The variant arises naturally in people who don ' t seem to get... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 11, 2024 Category: General Medicine Source Type: news
A little too obsessed with Taylor Swift? It might be a coping mechanism
In 'The Age of Magical Overthinking,' Amanda Montell observes how information overload and online culture has hijacked our brain's hard-wired vulnerabilities. (Source: L.A. Times - Health)
Source: L.A. Times - Health - April 11, 2024 Category: Consumer Health News Authors: Angela Chen Source Type: news
Use and consequences of less-lethal weapons in France: a neurosurgical perspective - Le Petit L, Jecko V, Coll G, Roblot P.
Highlights
• Crowd control measures in France typically involve the use of non-lethal weapons.
• Some protesters may suffer from craniocerebral injuries.
• Such weapons lead to severe cognitive impairments.
• We aim to alert both law enfor... (Source: SafetyLit)
Source: SafetyLit - April 11, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Neuropathic pain and mood disorders in earthquake survivors with peripheral nerve injuries - Halil AC, Gul BM, Rumeysa P, Zulfikar A, Halit F, Mehmet Y.
BACKGROUND AND PURPOSE: Natural disasters, such as earthquakes, frequently result in mood disorders among affected individuals. It is established that neuropathic pain arising from traumatic neuropathies is also linked to mood disorders. This st... (Source: SafetyLit)
Source: SafetyLit - April 11, 2024 Category: International Medicine & Public Health Tags: Disaster Preparedness Source Type: news
The effects of home automation on personal and social autonomies in spinal cord injury patients: a pilot study - Maresca G, Latella D, Formica C, Veneziani I, Ielo A, Quartarone A, Calabr ò RS, De Cola MC.
BACKGROUND: Spinal cord injury (SCI) is a severe and progressive neurological condition caused by trauma to the nervous system, resulting in lifelong disability and severe comorbidities. This condition imposes serious limitations on everyday life, interfer... (Source: SafetyLit)
Source: SafetyLit - April 11, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Childhood maltreatment influences adult brain structure through its effects on immune, metabolic, and psychosocial factors - Orellana SC, Bethlehem RAI, Simpson-Kent IL, van Harmelen AL, V értes PE, Bullmore ET.
Childhood maltreatment (CM) leads to a lifelong susceptibility to mental ill-health which might be reflected by its effects on adult brain structure, perhaps indirectly mediated by its effects on adult metabolic, immune, and psychosocial systems. Indexing ... (Source: SafetyLit)
Source: SafetyLit - April 11, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Cranio-cervical and traumatic brain injury patterns-do they differ between electric bicycle, bicycle, and motorcycle-induced accidents? - Rauer T, Klingebiel FKL, L ühring A, Küffer A, Hofer AS, Ferrari RM, Kupka M, Pape HC.
PURPOSE: With the growing technical options of power transmission and energy-saving options in electric drives, the number of E-bike-related accidents especially in an elderly population has increased. The aim of the current study was to compare if the inc... (Source: SafetyLit)
Source: SafetyLit - April 11, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Subarachnoid hemorrhage confirmed by magnetic resonance imaging in a patient with brain death owing to hypoxic encephalopathy following suicide by hanging - Oshida S, Yokosawa T, Araya S, Sato S, Suzuki T, Akamatsu Y, Ogasawara K.
Although true subarachnoid hemorrhage (SAH) is an atypical complication owing to suicide by hanging, pseudo-SAH can often develop because of hypoxic encephalopathy. Therefore, differentiating pseudo-SAH from true SAH using brain computed tomography (CT) is... (Source: SafetyLit)
Source: SafetyLit - April 11, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Trends of anti-seizure medication prescribing pattern in traumatic brain injury patients for the prevention of posttraumatic seizure in Taiwan - Lee HT, Liao FF, Kung SS, Hwang SJ, Hsieh KP.
Traumatic brain injury (TBI) patients are recommended to receive anti-seizure medication (ASM) as posttraumatic seizure (PTS) prophylaxis. However, the utilization of ASM, including the prescription patterns and associated clinical characteristics, is limi... (Source: SafetyLit)
Source: SafetyLit - April 11, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Effects of poloxamer 188 on traumatic brain injury - Wu R, Koduri R, Cho M, Alatrash N, Nomellini V.
Traumatic Brain Injury (TBI) is a major cause of severe disability and death, resulting in significant health care and economic burden. Poloxamer 188, a synthetic tri-block copolymer approved by the FDA, has been studied for its potential effects on trauma... (Source: SafetyLit)
Source: SafetyLit - April 11, 2024 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news
Defining mild traumatic brain injury: from research definition to clinical practice - Harris K, Brusnahan A, Shugar S, Miner J.
INTRODUCTION: Approximately 75% of traumatic brain injuries (TBIs) qualify as mild. However, there exists no universally agreed upon definition for mild TBI (mTBI). Consequently, treatment guidelines for this group are lacking. The Center for Disease Contr... (Source: SafetyLit)
Source: SafetyLit - April 11, 2024 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
The Elecsys ® pTau217 plasma biomarker test is being developed as part of an ongoing partnership between Roche and Eli Lilly and CompanyOnce approved, the test will aid healthcare providers in identifying amyloid pathology, a key feature of Alzheimer ’s diseaseRoche and Lilly believe the test could play an important role in improving access to early and accurate Alzheimer ’s diagnosisBasel, 11 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is being developed ...
Source: Roche Investor Update - April 11, 2024 Category: Pharmaceuticals Source Type: news
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
The Elecsys ® pTau217 plasma biomarker test is being developed as part of an ongoing partnership between Roche and Eli Lilly and CompanyOnce approved, the test will aid healthcare providers in identifying amyloid pathology, a key feature of Alzheimer ’s diseaseRoche and Lilly believe the test could play an important role in improving access to early and accurate Alzheimer ’s diagnosisBasel, 11 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is being developed ...
Source: Roche Media News - April 11, 2024 Category: Pharmaceuticals Source Type: news
